4//SEC Filing
Tracon Pharmaceuticals, Inc. 4
Accession 0001209191-15-071924
CIK 0001394319operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 7:30 PM ET
Size
8.8 KB
Accession
0001209191-15-071924
Insider Transaction Report
Form 4
LOGAN H CASEY
Chief Business Officer
Transactions
- Sale
Common Stock
2015-09-18$17.34/sh−5,000$86,700→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-09-18−5,000→ 80,270 totalExercise: $1.34Exp: 2023-03-13→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-09-18$1.34/sh+5,000$6,700→ 5,000 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2015
- [F2]1/4 of the shares subject to the option vested on February 19, 2014, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Tracon Pharmaceuticals, Inc.
CIK 0001394319
Entity typeoperating
Related Parties
1- filerCIK 0001394319
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 7:30 PM ET
- Size
- 8.8 KB